Skip to main content

Want a detailed portfolio tracker?

Cue Biopharma (CUE) P/E (2018 - 2026)

Cue Biopharma (CUE) P/E from Jan 2, 2018 to Jul 21, 2026. The TTM Cue Biopharma (CUE) P/E is -4.58. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cue Biopharma (CUE)

YearP/EChange
2026-4.58+483.39%
2025-0.79-45.17%
2024-1.43-35.52%
2023-2.22+6.07%
2022-2.09-73.86%
2021-8.01-0.73%
2020-8.07-17.14%
2019-9.74+298.19%
2018-2.44N/A

Comparison Cue Biopharma (CUE) P/E with competitors

Cue Biopharma (CUE) P/E is -4.58.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.09%
ENLVEnlivex Ltd0.07-101.63%
FGENFibroGen Inc0.24-105.24%
CHRSCoherus Biosciences Inc0.85-118.52%
FBIOFortress Biotech Inc0.95-120.72%
ORMPOramed Pharmaceuticals Inc1.50-132.81%
AGENAgenus Inc3.01-165.70%
INVAInnoviva Inc3.15-168.86%
VXRTVaxart Inc3.55-177.49%
CRMDCorMedix Inc3.63-179.21%
GLPGGalapagos NV4.86-206.07%
SRPTSarepta Therapeutics Inc4.88-206.58%
ABEOAbeona Therapeutics Inc5.39-217.62%
ABUSArbutus Biopharma Corp5.60-222.16%
ZVRAZevra Therapeutics Inc5.89-228.52%
SPROSpero Therapeutics Inc6.23-235.97%
CGENCompugen Ltd6.31-237.84%
RIGLRigel Pharmaceuticals6.87-250.02%
SLXNSilexion Therapeutics Corp7.30-259.28%
OMEROmeros Corporation9.26-302.13%
AUPHAurinia Pharmaceuticals Inc9.58-309.25%
PLXProtalix BioTherapeutics Inc10.89-337.76%
ACADAcadia Pharmaceuticals Inc11.73-356.05%
TBPHTheravance Biopharma Inc12.26-367.70%
ADMAAdma Biologics Inc12.42-371.10%
HRMYHarmony Biosciences Holdings Inc13.82-401.71%
SABSSAB Biotherapeutics Inc14.14-408.61%
NAGENiagen Bioscience Inc14.82-423.50%
INCYIncyte Corp15.82-445.43%
REGNRegeneron Pharmaceuticals Inc15.86-446.17%
PBYIPuma Biotechnology Inc17.32-478.02%
CPRXCatalyst Pharmaceuticals Inc17.44-480.72%
EXELExelixis Inc17.54-482.88%
TGTXTG Therapeutics Inc18.97-514.05%
MDXGMimedx Group Inc20.55-548.69%
XOMAXOMA Royalty Corp22.87-599.40%
ARGXArgen X SE24.30-630.47%
CTMXCytomX Therapeutics Inc24.82-641.89%
XOMAOXOMA Royalty Corp25.34-653.32%
HALOHalozyme Therapeutics Inc25.62-659.41%
XOMAPXOMA Royalty Corp25.67-660.42%
VRTXVertex Pharmaceuticals Inc27.99-711.17%
RPRXRoyalty Pharma plc - Class A28.69-726.30%
SLNOSoleno Therapeutics Inc29.02-733.46%
ASNDAscendis Pharma A/S30.09-756.82%
LGNDLigand Pharmaceuticals Inc - Class B37.91-927.69%
APLSApellis Pharmaceuticals Inc39.02-951.90%
BMRNBiomarin Pharmaceutical Inc42.21-1021.56%
KRYSKrystal Biotech Inc45.34-1089.93%
ONCBeiGene Ltd69.54-1618.19%
PHARPharming Group N.V.75.03-1737.94%
TECHBio-Techne Corp101.96-2325.93%
VCELVericel Corp109.92-2499.78%
ALNYAlnylam Pharmaceuticals Inc117.96-2675.39%
GMABGenmab140.29-3162.80%
TLXTelix Pharmaceuticals Ltd162.15-3640.09%
CORTCorcept Therapeutics Inc212.86-4747.06%